QOOLABS INC
- CARLSBAD, CA 92008-7307
- qoolabs.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
- Small Business
- Women-Owned Small Business
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $3.3M
- Awards on record
- 3
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
QOOLABS INC has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About QOOLABS INC
- Headquarters
- CARLSBAD, CA 92008-7307
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIK7HZKKAMVHK5
- CAGE6NLR3
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $3.3M
- Awards on record
- 3
- Top funding agencies
- National Institutes of Health
Awards
75N93023C00049
Completed: Period of performance ended Oct 31, 2026SBIR PHASE II
Department of Health and Human Services · National Institutes of Health
- Obligated
- $1.5M
- Period of performance
- Sep 15, 2023 – Oct 31, 2026
75N93024C00046
Completed: Period of performance ended Sep 9, 2025SBIR 133 - QOOLABS
Department of Health and Human Services · National Institutes of Health
- Obligated
- $300K
- Period of performance
- Sep 10, 2024 – Sep 9, 2025
75N93025C00012
Completed: Period of performance ended Apr 10, 2025AFFINITY REAGENTS FOR THE IMMUNE SYSTEM OF GUINEA PIGS IL1B, IL2, IL4, IL6, IL8, IL10, IL12, AND IL13.
Department of Health and Human Services · National Institutes of Health
- Obligated
- $1.5M
- Period of performance
- Feb 1, 2025 – Apr 10, 2025
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
75N93023C00049 SBIR PHASE II | Department of Health and Human Services · National Institutes of Health | 541714 · AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $1.5M | Sep 15, 2023 – Oct 31, 2026 | Completed: Period of performance ended Oct 31, 2026 |
75N93024C00046 SBIR 133 - QOOLABS | Department of Health and Human Services · National Institutes of Health | 541715 · AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $300K | Sep 10, 2024 – Sep 9, 2025 | Completed: Period of performance ended Sep 9, 2025 |
75N93025C00012 AFFINITY REAGENTS FOR THE IMMUNE SYSTEM OF GUINEA PIGS IL1B, IL2, IL4, IL6, IL8, IL10, IL12, AND IL13. | Department of Health and Human Services · National Institutes of Health | 541714 · AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $1.5M | Feb 1, 2025 – Apr 10, 2025 | Completed: Period of performance ended Apr 10, 2025 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 16 awards
- Total awarded
- $7,488,575
- By phase
- SBIR Phase I: 13
- SBIR Phase II: 3
- By agency
- Department of Health and Human Services: 16
- Active projects
- 0 projects
- Projects whose contract end date is today or later.
- Phase II ending within 12 months
- 0 projects
- Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
- By year
- 2025: 1
- 2024: 1
- 2023: 1
- 2022: 3
- 2021: 2
- 2020: 1
- 2018: 1
- 2017: 2
- 2016: 1
- 2015: 1
- 2014: 2
Awards (most recent first)
AFFINITY REAGENTS FOR THE IMMUNE SYSTEM OF GUINEA PIGS IL1B, IL2, IL4, IL6, IL8, IL10, IL12, AND IL13.
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2025 · $1,500,000
- Direct to Phase II
Solicitation PHS 2024-1 (2024) · Topic 129
SBIR Topic 133: Development of a Serological Test for Herpes Simplex Types 1 and 2 Infections
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2024 · $300,000
Solicitation PHS-2024-1 (2024) · Topic 133
Affinity Reagents for the Immune System of Golden Hamster (for SARS-CoV-2 induced long-COVID disease)
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2023 · $600,000
Solicitation PHS-2023-1 (2023) · Topic 118
Rapid at-home Detection for Serologic Status of Hepatitis C Virus (HCV) Infection
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2022 · $400,000
Solicitation PHS-2022-1 (2021) · Topic 441
SBIR TOPIC 107 MONOCLONAL ANTIBODIES FOR THE IMMUNE TARGETS OF SWINE
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2022 · $600,000
Solicitation PHS-2022-1 (2021) · Topic 107
SBIR TOPIC 107 AFFINITY REAGENTS FOR THE IMMUNE SYSTEM OF GOLDEN HAMSTER
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2022 · $600,000
Solicitation PHS-2022-1 (2021) · Topic 107
AFFINITY REAGENTS FOR THE IMMUNE SYSTEM OF GUINEA PIGS
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2021 · $300,000
Solicitation PHS2021-1 (2020) · Topic 94
POINT-OF-CARE HCV CORE ANTIGEN DETECTION
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2021 · $300,000
Solicitation PHS2021-1 (2020) · Topic 99
AFFINITY REAGENTS FOR THE IMMUNE SYSTEM OF GUINEA PIGS
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2020 · $300,000
Solicitation year 2019 · Topic 83
Developing Species Specific Human Taeniasis Coproantigen Detection Immunoassays
SBIR Phase I · Department of Health and Human Services (Centers for Disease Control and Prevention) · 2018 · $150,000
Solicitation year 2018 · Topic ODCDC
Immunoassay for Serological Detection and Quantification of Hepatitis B Core Anti en
SBIR Phase II · Department of Health and Human Services (Centers for Disease Control and Prevention) · 2017 · $749,999
Solicitation year 2017 · Topic ODCDC
RAPID POINT OF CARE DETECTION TESTS FOR SEROLOGIC STATUS OF INDIVIDUALS FOR CMV AND HSV INFECTIONS
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2017 · $225,000
Solicitation year 2017 · Topic NIAID
Immunoassay for Serological Detection and Quantification of Hepatitis B Core Antigen
SBIR Phase I · Department of Health and Human Services (Centers for Disease Control and Prevention) · 2016 · $150,000
Solicitation year 2016 · Topic ODCDC
Rapid Test for HCV Core Antigen
SBIR Phase II · Department of Health and Human Services (Centers for Disease Control and Prevention) · 2015 · $718,000
Solicitation year 2015 · Topic ODCDC
Development of a Biomarker Based assay for Hepato cellular Carcinoma -- Rapid test for HCV Core Antigen
SBIR Phase I · Department of Health and Human Services (Centers for Disease Control and Prevention) · 2014 · $150,000
Sep 1, 2014 – Mar 29, 2015
Lateral Flow Immunoassay POC Device for the Diagnosis of Sickle Cell Disease
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2014 · $445,576
Aug 6, 2014 – Jun 30, 2016
Solicitation HL14-010 (2016) · Topic NHLBI
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 541714Research and Development in Biotechnology (except Nanobiotechnology)PrimarySmall business under this code’s size standard
- 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov reports this entity as small under 1 of 2 NAICS codes. Size is determined per code (SBA size standards).
Socio-economic status
Self-represented in SAM.gov. WOSB and EDWOSB set-asides need SBA certification (13 CFR 127.300); SDVOSB and VOSB need SBA VetCert (13 CFR part 128). Confirm current certification before relying on it.
Learn more about small business set-asidesProduct & service codes (PSC)
- 6505DRUGS AND BIOLOGICALS
- 6550IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
PSC names from the Acquisition.gov PSC Manual (opens in a new tab) (April 2025 edition), checked Nov 12, 2026.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with QOOLABS INC?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.
